XML 57 R29.htm IDEA: XBRL DOCUMENT
v3.25.4

Revenue Recognition (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Revenue from Contract with Customer [Abstract] |
Schedule of net revenue from collaboration arrangement | Net revenue recognized under our GSK Agreements was as follows:
|  | Year Ended December 31, |
(In thousands) |  | 2025 |  |  | 2024 |  |  | 2023 |
Royalties – RELVAR/BREO |  | $ | 204,021 |  |  | $ | 207,925 |  |  | $ | 208,042 |
Royalties – ANORO |  |  | 46,281 |  |  |  | 47,631 |  |  |  | 44,627 |
Total royalties |  |  | 250,302 |  |  |  | 255,556 |  |  |  | 252,669 |
Less: amortization of capitalized fees paid |  |  | (13,823 | ) |  |  | (13,823 | ) |  |  | (13,823 | )
Total royalty revenue |  | $ | 236,479 |  |  | $ | 241,733 |  |  | $ | 238,846 |
Schedule of net product sales | Total net product sales were as follows:
|  | Year Ended December 31, |
(In thousands) |  | 2025 |  |  | 2024 |  |  | 2023 |
GIAPREZA® |  | $ | 73,611 |  |  | $ | 55,037 |  |  | $ | 41,294 |
XACDURO® |  |  | 74,393 |  |  |  | 21,070 |  |  |  | 2,003 |
XERAVA® |  |  | 23,516 |  |  |  | 21,385 |  |  |  | 17,320 |
ZEVTERA® |  |  | 610 |  |  |  | — |  |  |  | — |
Total net product sales |  | $ | 172,130 |  |  | $ | 97,492 |  |  | $ | 60,617 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration